This article was accepted into the corpus but its outbound wikilinks were never NER-processed — typical at the deepest BFS hop or when the run's entity cap was reached. No expansion funnel to show.
| Liggins Institute | |
|---|---|
| Name | Liggins Institute |
| Established | 1988 |
| Type | Research institute |
| Parent | University of Auckland |
| Location | Auckland, New Zealand |
| Fields | Perinatal biology, developmental origins of health and disease, obstetrics, neonatology |
Liggins Institute is a biomedical research institute based in Auckland, New Zealand, focused on perinatal biology, developmental origins of health and disease, obstetrics and neonatology. The institute conducts basic, translational and clinical research, and links to public health, pediatrics and endocrinology. It collaborates with international universities, hospitals and research organizations to influence guidelines, policy and clinical practice in maternal and child health.
Founded in 1988, the institute emerged amid shifts in perinatal research linked to pioneers such as David Barker, Peter Gluckman, Alfred W. Cox, Sir Graham Liggins, and institutions including University of Auckland, University of Oxford, University of Cambridge, Harvard University, and University of Melbourne. Early work referenced developmental hypotheses from Barker hypothesis debates and drew on cohorts established by groups like Fetal Origins Research and studies related to Dutch famine cohorts, the Helsinki Birth Cohort Study, and the National Children's Study. Over decades the institute interacted with organizations such as World Health Organization, Wellcome Trust, Marsden Fund, National Institutes of Health, and European Research Council while contributing to policy discussions involving New Zealand Ministry of Health, Royal College of Obstetricians and Gynaecologists, and Royal Australasian College of Physicians.
Research programs address fetal programming, placental biology, preterm birth, gestational diabetes, intrauterine growth restriction, and long-term cardiometabolic outcomes drawing on frameworks established by DOHaD proponents and linking to fields represented by Institute of Child Health, MRC Epidemiology Unit, Karolinska Institutet, Monash University, and University of California, San Francisco. Projects range from molecular studies leveraging techniques from CRISPR-Cas9 gene editing and RNA sequencing to clinical trials employing designs referenced by CONSORT and translational pipelines similar to Translational Medicine initiatives at Johns Hopkins University and Mayo Clinic. The institute runs cohorts analogous to Avon Longitudinal Study of Parents and Children, Framingham Heart Study, and Dunedin Multidisciplinary Health and Development Study, and engages in biomarker discovery tied to standards from European Society of Human Reproduction and Embryology and International Society for Prenatal Diagnosis.
Located within premises associated with University of Auckland and adjacent to clinical services at Auckland City Hospital, the institute shares infrastructure with departments such as Faculty of Medical and Health Sciences, School of Biological Sciences, Department of Obstetrics and Gynaecology, and allied units like Liggins Clinical Trials Unit and Maurice Wilkins Centre. Laboratories feature instrumentation comparable to facilities at Wellcome Trust Sanger Institute and EMBL, including mass spectrometry platforms akin to Thermo Fisher Scientific installations, high-throughput genomics comparable to Illumina centers, and imaging suites reflecting standards at Cancer Research UK centers. Its clinical links mirror affiliations between academic centers and hospitals like Royal Prince Alfred Hospital and Karolinska University Hospital.
Leadership and contributors have included figures comparable to Sir Peter Gluckman, researchers engaged with networks such as Marie Skłodowska-Curie Actions, and collaborators from groups led by investigators at Harvard T.H. Chan School of Public Health, University of Cambridge Metabolic Research Laboratories, University of Oxford Nuffield Department of Obstetrics and Gynaecology, and Monash Biomedicine Discovery Institute. Faculty and visiting scientists have connections to scholars from Stanford University School of Medicine, Imperial College London, Max Planck Institute, Salk Institute, Karolinska Institutet, University of Toronto, University of Sydney, and University of British Columbia.
The institute provides postgraduate programs, doctoral supervision and postdoctoral training consistent with frameworks at Edinburgh Medical School, Yale School of Medicine, Columbia University Mailman School of Public Health, and Australian National University. Training emphasizes clinical trial methodology akin to courses at London School of Hygiene & Tropical Medicine, laboratory techniques paralleling curricula at Cold Spring Harbor Laboratory, and statistical approaches taught at MRC Biostatistics Unit. Students rotate through clinical sites such as Starship Children's Hospital and research centers like Griffith University laboratories.
International partnerships include research agreements and consortia with World Health Organization, European Centre for Disease Prevention and Control, NIH-funded networks, and universities such as University of Oxford, Harvard University, University of Melbourne, Monash University, Karolinska Institutet, University of Toronto, Duke University, University of California, San Diego, and University of British Columbia. Collaborative clinical networks mirror structures like Global Network for Women's and Children's Health Research and engage with funders such as Wellcome Trust, Marsden Fund, Health Research Council of New Zealand, European Research Council, and Bill & Melinda Gates Foundation.
The institute has influenced understanding of developmental origins of health and disease linked to cardiovascular risk, metabolic disorders, neurodevelopmental outcomes and public health policy; its outputs have paralleled landmark findings from Barker hypothesis literature and cohort studies such as ALSPAC and Dunedin Study. Its translational work informed clinical practice guidelines from bodies like Royal College of Obstetricians and Gynaecologists and contributed to debates in forums including World Congress of Perinatal Medicine, International Society for Developmental Origins of Health and Disease, and policy discussions involving New Zealand Ministry of Health and Health Research Council of New Zealand. Collaborations have led to clinical trials comparable to those from Cochrane Collaboration-referenced studies and to biomarker and mechanistic discoveries cited alongside research from Massachusetts General Hospital and Johns Hopkins Hospital.
Category:Medical research institutes